STSS - Sharps Technology Inc.


1.79
-0.060   -3.352%

Share volume: 126,294
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$1.85
-0.06
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
33%
Profitability 35%
Dept financing 36%
Liquidity 31%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
0.56%
1 Month
2.29%
3 Months
-30.62%
6 Months
-82.52%
1 Year
503.30%
2 Year
402.24%
Key data
Stock price
$1.79
P/E Ratio 
0.00
DAY RANGE
$1.77 - $1.86
EPS 
$30.59
52 WEEK RANGE
$0.01 - $18.23
52 WEEK CHANGE
$306.82
MARKET CAP 
6.671 M
YIELD 
N/A
SHARES OUTSTANDING 
28.226 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.08
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$370,844
AVERAGE 30 VOLUME 
$319,831
Company detail
CEO: Robert M. Hayes
Region: US
Website: sharpstechnology.com
Employees: 3
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Sharps Technology Inc. researches, designs, develops, manufactures, distributes, and sells safety syringe products. Sharps Provensa is an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Recent news